Senseonics Holdings, Inc.

Senseonics Announces European Launch of Eversense® 365, The World’s First and Only One Year CGM System

First Ever Real-World Evidence of Eversense 365 Presented at ATTD Demonstrates Sustained Performance and Positive Impact Throughout One-Year of Wear

Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results

Sequel Med Tech and Senseonics Launch Transformative Combination of twiist™ and Eversense® 365

Senseonics Receives European Approval for Eversense 365, World’s Longest-lasting Continuous Glucose Monitor